Zura Bio Ltd announced on February 24, 2026, that it will issue 18.2 million shares at $6.25 each, aiming for about $134.6 million in net proceeds, with closing expected on February 26, 2026. The offering includes an option for underwriters to purchase an additional 3 million shares at the same price.